2YCR
| Crystal structure of checkpoint kinase 2 in complex with inhibitor PV976 | 分子名称: | 1,3-BIS{4-[(1E)-N-(4,5-DIHYDRO-1H-IMIDAZOL-2-YL)ETHANEHYDRAZONOYL]PHENYL}UREA, NITRATE ION, SERINE/THREONINE-PROTEIN KINASE CHK2 | 著者 | Lountos, G.T, Jobson, A.G, Tropea, J.E, Self, C.R, Pommier, Y, Shoemaker, R.H, Zhang, G, Waugh, D.S. | 登録日 | 2011-03-16 | 公開日 | 2011-11-16 | 最終更新日 | 2023-12-20 | 実験手法 | X-RAY DIFFRACTION (2.2 Å) | 主引用文献 | Structural Characterization of Inhibitor Complexes with Checkpoint Kinase 2 (Chk2), a Drug Target for Cancer Therapy. J.Struct.Biol., 176, 2011
|
|
5P68
| |
5P1O
| |
5P6N
| |
5P72
| |
5P1Y
| |
5P7F
| |
1WSE
| Co-crystal structure of E.coli RNase HI active site mutant (E48A*) with Mn2+ | 分子名称: | MANGANESE (II) ION, Ribonuclease HI | 著者 | Tsunaka, Y, Takano, K, Matsumura, H, Yamagata, Y, Kanaya, S. | 登録日 | 2004-11-05 | 公開日 | 2005-02-08 | 最終更新日 | 2024-05-29 | 実験手法 | X-RAY DIFFRACTION (2.3 Å) | 主引用文献 | Identification of Single Mn(2+) Binding Sites Required for Activation of the Mutant Proteins of E.coli RNase HI at Glu48 and/or Asp134 by X-ray Crystallography J.Mol.Biol., 345, 2005
|
|
5P2C
| |
5P7Y
| |
5P8E
| |
1WFO
| |
5P2Q
| |
1HPT
| |
5P34
| |
5P8T
| |
5P3I
| |
5P3Z
| |
2CPP
| |
5P4E
| |
1S81
| PORCINE TRYPSIN WITH NO INHIBITOR BOUND | 分子名称: | 1,2-ETHANEDIOL, CALCIUM ION, SODIUM ION, ... | 著者 | Transue, T.R, Krahn, J.M, Gabel, S.A, DeRose, E.F, London, R.E. | 登録日 | 2004-01-30 | 公開日 | 2004-03-16 | 最終更新日 | 2023-08-23 | 実験手法 | X-RAY DIFFRACTION (1.7 Å) | 主引用文献 | X-ray and NMR characterization of covalent complexes of trypsin, borate, and alcohols. Biochemistry, 43, 2004
|
|
3FPM
| Crystal Structure of a Squarate Inhibitor bound to MAPKAP Kinase-2 | 分子名称: | 3-{[(1R)-1-phenylethyl]amino}-4-(pyridin-4-ylamino)cyclobut-3-ene-1,2-dione, MAP kinase-activated protein kinase 2 | 著者 | Parris, K.D. | 登録日 | 2009-01-05 | 公開日 | 2009-04-07 | 最終更新日 | 2023-09-06 | 実験手法 | X-RAY DIFFRACTION (3.3 Å) | 主引用文献 | Identification and SAR of squarate inhibitors of mitogen activated protein kinase-activated protein kinase 2 (MK-2) Bioorg.Med.Chem., 17, 2009
|
|
5P4W
| |
5P5C
| |
5P5R
| |